Safe and Interpretable Estimation of Optimal Treatment Regimes
Harsh Parikh, Quinn Lanners, Zade Akras, Sahar F. Zafar, M. Brandon Westover, Cynthia Rudin, Alexander Volfovsky
TL;DR
This work develops a safe, interpretable framework to estimate patient-specific optimal treatment regimes for seizures in critically ill patients by integrating mechanistic PK/PD modeling, distance-metric learning, and interpolation across matched patients. It addresses challenges typical of high-stakes medical data—missingness, continuous dosing, and small sample sizes—without relying on predefined rewards. Through extensive synthetic experiments and a real ICU seizure cohort, the method demonstrates robust performance, improved outcomes, and actionable dosing insights, particularly for high-risk subgroups. The clinical application suggests substantial potential to personalize ASM strategies and motivates future trials to validate heterogeneous causal effects in critical care.
Abstract
Recent statistical and reinforcement learning methods have significantly advanced patient care strategies. However, these approaches face substantial challenges in high-stakes contexts, including missing data, inherent stochasticity, and the critical requirements for interpretability and patient safety. Our work operationalizes a safe and interpretable framework to identify optimal treatment regimes. This approach involves matching patients with similar medical and pharmacological characteristics, allowing us to construct an optimal policy via interpolation. We perform a comprehensive simulation study to demonstrate the framework's ability to identify optimal policies even in complex settings. Ultimately, we operationalize our approach to study regimes for treating seizures in critically ill patients. Our findings strongly support personalized treatment strategies based on a patient's medical history and pharmacological features. Notably, we identify that reducing medication doses for patients with mild and brief seizure episodes while adopting aggressive treatment for patients in intensive care unit experiencing intense seizures leads to more favorable outcomes.
